Skip to main content

Effect of Apixaban on Clinical Outcomes in Outpatients With COVID-19: The APOLLO Randomized Clinical Trial.

Publication ,  Journal Article
de Barros E Silva, PGM; Macedo, AVS; Bronhara, B; Damiani, LP; Mazza Barbosa, L; Lopes, NR; Suiama, MA; Antunes, MO; Gonçalves, MR; Gebara, OCE ...
Published in: Circulation
July 2, 2024

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

July 2, 2024

Volume

150

Issue

1

Start / End Page

82 / 85

Location

United States

Related Subject Headings

  • Treatment Outcome
  • SARS-CoV-2
  • Pyridones
  • Pyrazoles
  • Outpatients
  • Middle Aged
  • Male
  • Humans
  • Female
  • Factor Xa Inhibitors
 

Citation

APA
Chicago
ICMJE
MLA
NLM
de Barros E Silva, P. G. M., Macedo, A. V. S., Bronhara, B., Damiani, L. P., Mazza Barbosa, L., Lopes, N. R., … Coalition COVID-19 Brazil Investigators. (2024). Effect of Apixaban on Clinical Outcomes in Outpatients With COVID-19: The APOLLO Randomized Clinical Trial. Circulation, 150(1), 82–85. https://doi.org/10.1161/CIRCULATIONAHA.123.066709
Barros E Silva, Pedro Gabriel Melo de, Ariane Vieira Scarlatelli Macedo, Bruna Bronhara, Lucas Petri Damiani, Lilian Mazza Barbosa, Nathália Rodrigues Lopes, Mayra Akimi Suiama, et al. “Effect of Apixaban on Clinical Outcomes in Outpatients With COVID-19: The APOLLO Randomized Clinical Trial.Circulation 150, no. 1 (July 2, 2024): 82–85. https://doi.org/10.1161/CIRCULATIONAHA.123.066709.
de Barros E Silva PGM, Macedo AVS, Bronhara B, Damiani LP, Mazza Barbosa L, Lopes NR, et al. Effect of Apixaban on Clinical Outcomes in Outpatients With COVID-19: The APOLLO Randomized Clinical Trial. Circulation. 2024 Jul 2;150(1):82–5.
de Barros E Silva, Pedro Gabriel Melo, et al. “Effect of Apixaban on Clinical Outcomes in Outpatients With COVID-19: The APOLLO Randomized Clinical Trial.Circulation, vol. 150, no. 1, July 2024, pp. 82–85. Pubmed, doi:10.1161/CIRCULATIONAHA.123.066709.
de Barros E Silva PGM, Macedo AVS, Bronhara B, Damiani LP, Mazza Barbosa L, Lopes NR, Suiama MA, Antunes MO, Gonçalves MR, Gebara OCE, de Aquino Martins P, Ribeiro MG, de Moura Xavier de Moraes JB, Aguiar VCR, Cavalcanti AB, Rosa RG, Berwanger O, Veiga VC, Azevedo LCP, Ramacciotti E, Granger CB, Alexander JH, Avezum A, Lopes RD, Coalition COVID-19 Brazil Investigators. Effect of Apixaban on Clinical Outcomes in Outpatients With COVID-19: The APOLLO Randomized Clinical Trial. Circulation. 2024 Jul 2;150(1):82–85.

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

July 2, 2024

Volume

150

Issue

1

Start / End Page

82 / 85

Location

United States

Related Subject Headings

  • Treatment Outcome
  • SARS-CoV-2
  • Pyridones
  • Pyrazoles
  • Outpatients
  • Middle Aged
  • Male
  • Humans
  • Female
  • Factor Xa Inhibitors